Survival Rates in Patients with Liver Cancer
Author Information
Author(s): Greten T F, Papendorf F, Bleck J S, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns M P
Primary Institution: Medizinische Hochschule Hannover
Hypothesis
The study aims to determine current survival rates for patients diagnosed with hepatocellular carcinoma (HCC) and identify prognostic factors.
Conclusion
The study found that the overall median survival for HCC patients was 11 months, with various factors influencing survival rates.
Supporting Evidence
- 80.5% of patients had liver cirrhosis.
- Patients receiving TACE had a median survival of 16 months.
- Patients with Child B cirrhosis had a median survival of 6 months.
- Patients with a CLIP score of zero had a median survival of 36 months.
Takeaway
This study looked at patients with liver cancer and found that most lived about 11 months after being diagnosed, but some lived longer depending on their treatment and health.
Methodology
A retrospective analysis of medical records was performed on 389 patients diagnosed with HCC from 1998 to 2003.
Limitations
The study is retrospective and may not account for all variables affecting survival.
Participant Demographics
The average age of participants was 64 years, with a male to female ratio of 3.8:1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website